Remodeling after myocardial infarction and effects of heart failure treatment investigated by hyperpolarized [1-
MRS
animal models of human disease
heart failure
metabolism
myocardial infarction
remodeling
Journal
Magnetic resonance in medicine
ISSN: 1522-2594
Titre abrégé: Magn Reson Med
Pays: United States
ID NLM: 8505245
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
20
07
2021
received:
06
02
2021
accepted:
21
07
2021
pubmed:
12
8
2021
medline:
1
2
2022
entrez:
11
8
2021
Statut:
ppublish
Résumé
Hyperpolarized [1- Thirty-five rats were scanned with hyperpolarized [1- At 30 ± 0.5 days post MI, left ventricular ejection fraction (LVEF) differed between groups (sham, 77% ± 1%; placebo, 52% ± 3%; active, 63% ± 2%, P < .001). Cardiac metabolism, measured by both hyperpolarized [1- In a rat model of moderate heart failure, medical treatment improved function, but did not on average influence [1-
Substances chimiques
Pyruvic Acid
8558G7RUTR
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
57-69Informations de copyright
© 2021 International Society for Magnetic Resonance in Medicine.
Références
Neubauer S. The failing heart-an engine out of fuel. N Engl J Med. 2007;356:1140-1151.
Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-1129.
Taegtmeyer H. Cardiac metabolism as a target for the treatment of heart failure. Circulation. 2004;110:894-896.
Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207-258.
Schroeder MA, Lau AZ, Chen AP, et al. Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart. Eur J Heart Fail. 2013;15:130-140.
Rider OJ, Tyler DJ. Clinical implications of cardiac hyperpolarized magnetic resonance imaging. J Cardiovasc Magn Reson. 2013;15:1-9.
Obrzut S, Jamshidi N, Karimi A, Birgersdotter-Green U, Hoh C. Imaging and modeling of myocardial metabolism. J Cardiovasc Transl Res. 2010;3:384-396.
Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci USA. 2003;100:10158-10163.
Ball DR, Cruickshank R, Carr CA, et al. Metabolic imaging of acute and chronic infarction in the perfused rat heart using hyperpolarised [1-13C]pyruvate. NMR Biomed. 2013;26:1441-1450.
Merritt ME, Harrison C, Storey C, Sherry AD, Malloy CR. Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO3-. Magn Reson Med. 2008;60:1029-1036.
Dodd MS, Atherton HJ, Carr CA, et al. Impaired in vivo mitochondrial Krebs cycle activity after myocardial infarction assessed using hyperpolarized magnetic resonance spectroscopy. Circ Cardiovasc Imaging. 2014;7:895-904.
Yoshihara HAI, Bastiaansen JAM, Berthonneche C, Comment A, Schwitter J. An intact small animal model of myocardial ischemia-reperfusion: characterization of metabolic changes by hyperpolarized 13C MR spectroscopy. Am J Physiol Heart Circ Physiol. 2015;309:H2058-H2066.
Oh-Ici D, Wespi P, Busch J, et al. Hyperpolarized metabolic MR imaging of acute myocardial changes and recovery after ischemia-reperfusion in a small-animal model. Radiology. 2016;278:742-751.
Lewis AJM, Miller JJ, Lau AZ, et al. Noninvasive immunometabolic cardiac inflammation imaging using hyperpolarized magnetic resonance. Circ Res. 2018;122:1084-1093.
Golman K, Petersson JS, Magnusson P, et al. Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI. Magn Reson Med. 2008;59:1005-1013.
Atherton HJ, Dodd MS, Heather LC, et al. Role of pyruvate dehydrogenase inhibition in the development of hypertrophy in the hyperthyroid rat heart: a combined magnetic resonance imaging and hyperpolarized magnetic resonance spectroscopy study. Circulation. 2011;123:2552-2561.
Dodd MS, Ball DR, Schroeder MA, et al. In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. Cardiovasc Res. 2012;95:69-76.
Seymour A-ML, Giles L, Ball V, et al. In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy. Cardiovasc Res. 2015;106:249-260.
Charles CJ, Lee P, Li RR, et al. A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics. ESC Heart Fail. 2020;7:92-102.
Schroeder MA, Cochlin LE, Heather LC, Clarke K, Radda GK, Tyler DJ. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci USA. 2008;105:12051-12056.
Lewis AJM, Miller JJJ, McCallum C, et al. Assessment of metformin-induced changes in cardiac and hepatic redox state using hyperpolarized[1-13C]pyruvate. Diabetes. 2016;65:3544-3551.
Le Page LM, Ball DR, Ball V, et al. Simultaneous in vivo assessment of cardiac and hepatic metabolism in the diabetic rat using hyperpolarized MRS. NMR Biomed. 2016;29:1759-1767.
Abdurrachim D, Teo XQ, Woo CC, et al. Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: a hyperpolarized 13 C magnetic resonance spectroscopy study. Diabetes Obes Metab. 2019;21:357-365.
Agger P, Hyldebrandt JA, Hansen ESS, et al. Magnetic resonance hyperpolarization imaging detects early myocardial dysfunction in a porcine model of right ventricular heart failure. Eur Heart J Cardiovasc Imaging. 2019;120:1-9.
Bøgh N, Hansen ESS, Omann C, et al. Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure. Sci Rep. 2020;10:8158.
Beanlands RS, Nahmias C, Gordon E, et al. The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: a double-blind, placebo-controlled, positron-emission tomography study. Circulation. 2000;102:2070-2075.
Wallhaus TR, Taylor M, Degrado TR, et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation. 2001;103:2441-2446.
Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization. Eur J Heart Fail. 2005;7:618-623.
Sanbe A, Tanonaka K, Kobayasi R, Takeo S. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol. 1995;27:2209-2222.
Hügel S, Horn M, de Groot M, et al. Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction. Am J Physiol. 1999;277:H2167-H2175.
Cunningham CH, Lau JY, Chen AP, et al. Hyperpolarized 13C metabolic MRI of the human heart: initial experience. Circ Res. 2016;119:1177-1182. https://doi.org/10.1161/CIRCRESAHA.116.309769.
Rider OJ, Apps A, Miller JJJJ, et al. Noninvasive in vivo assessment of cardiac metabolism in the healthy and diabetic human heart using hyperpolarized 13C MRI. Circ Res. 2020;126:725-736.
Theres HP, Wagner KD, Romberg D, et al. Combined treatment with ramipril and metoprolol prevents changes in the creatine kinase isoenzyme system and improves hemodynamic function in rat hearts after myocardial infarction. Cardiovasc Drugs Ther. 2000;14:597-606.
Theres H, Wagner KD, Schulz S, et al. Oxygen radical system in chronic infarcted rat heart: the effect of combined beta blockade and ACE inhibition. J Cardiovasc Pharmacol. 2000;35:708-715.
Wagner K, Kamkin A, Kiseleva I, Theres H, Scholz H, Günther J. Effects of metoprolol and ramipril on action potentials after myocardial infarction in rats. Eur J Pharmacol. 2000;388:263-266.
Wagner KD, Theres H, Born A, et al. Contractile function of papillary muscle from rats with different infarct size after beta-adrenergic blockade and ACE-inhibition. J Mol Cell Cardiol. 1997;29:2941-2951.
Lassen TR, Nielsen JM, Johnsen J, Ringgaard S, Bøtker HE, Kristiansen SB. Effect of paroxetine on left ventricular remodeling in an in vivo rat model of myocardial infarction. Basic Res Cardiol. 2017;112:26.
Jespersen NR, Yokota T, Støttrup NB, et al. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion. J Physiol (Lond.). 2017;595:3765-3780.
Jespersen NR, Hjortbak MV, Lassen TR, et al. Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus. Sci Rep. 2020;10:10344.
Groennebaek T, Sieljacks P, Nielsen R, et al. Effect of blood flow restricted resistance exercise and remote ischemic conditioning on functional capacity and myocellular adaptations in patients with heart failure. Circulation: Heart Failure. 2019;12:e006427.
Heiberg E, Sjögren J, Ugander M, Carlsson M, Engblom H, Arheden H. Design and validation of segment-freely available software for cardiovascular image analysis. BMC Med Imaging. 2010;10:1.
Stuckey DJ, Carr CA, Tyler DJ, Clarke K. Cine-MRI versus two-dimensional echocardiography to measure in vivo left ventricular function in rat heart. NMR Biomed. 2008;21:765-772.
Laustsen C, Lipsø K, Ostergaard JA, et al. Insufficient insulin administration to diabetic rats increases substrate utilization and maintains lactate production in the kidney. Physiol Rep. 2014;2:e12233.
Tougaard RS, Hansen ESS, Laustsen C, et al. Acute hypertensive stress imaged by cardiac hyperpolarized [1-13C]pyruvate magnetic resonance. Magn Reson Med. 2018;80:2053-2061.
van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ. Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc Res. 2008;81:420-428.
Panchal AR, Stanley WC, Kerner J, Sabbah HN. Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure. J Card Fail. 1998;4:121-126.
Lee L, Horowitz J, Frenneaux M. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J. 2004;25:634-641.
Mueller HS, Ayres SM. Metabolic response of the heart in acute myocardial infarction in man. Am J Cardiol. 1978;42:363-371.
Lopatin Y. Metabolic therapy in heart failure. Card Fail Rev. 2015;1:112-117.
Peuhkurinen KJ, Hiltunen JK, Hassinen IE. Metabolic compartmentation of pyruvate in the isolated perfused rat heart. Biochem J. 1983;210:193-198.
Peuhkurinen KJ, Nuutinen EM, Pietiläinen EP, Hiltunen JK, Hassinen IE. Role of pyruvate carboxylation in the energy-linked regulation of pool sizes of tricarboxylic acid-cycle intermediates in the myocardium. Biochem J. 1982;208:577-581.
Atherton HJ, Schroeder MA, Dodd MS, et al. Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS. NMR Biomed. 2011;24:201-208.
Lewandowski ED. Metabolic heterogeneity of carbon substrate utilization in mammalian heart: NMR determinations of mitochondrial versus cytosolic compartmentation. Biochemistry. 1992;31:8916-8923.
Wespi P, Steinhauser J, Kwiatkowski G, Kozerke S. Overestimation of cardiac lactate production caused by liver metabolism of hyperpolarized [1-13C]pyruvate. Magn Reson Med. 2018;80:1882-1890.